On this page of StockholderLetter.com we present the 4/25/2024 shareholder letter from Aclaris Therapeutics, Inc. — ticker symbol ACRS. Reading current and past ACRS letters to shareholders can bring important insights into the investment thesis.
2023 Annual Report
EMPOWERING PATIENTS THROUGH KINOME INNOVATION
 • shareholder letter icon 4/25/2024 Letter Continued (Full PDF)
 • stockholder letter icon 4/20/2023 ACRS Stockholder Letter
 • stockholder letter icon 4/24/2025 ACRS Stockholder Letter
 • stockholder letter icon More "Drugs & Pharmaceuticals" Category Stockholder Letters
 • Benford's Law Stocks icon ACRS Benford's Law Stock Score = 83


ACRS 4/25/2024 Shareholder/Stockholder Letter Transcript:


2023
Annual Report

EMPOWERING
PATIENTS THROUGH
KINOME INNOVATION



shareholder letter icon 4/25/2024 Letter Continued (Full PDF)
 

ACRS Stockholder/Shareholder Letter (Aclaris Therapeutics, Inc.) 4/25/2024 | www.StockholderLetter.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.